Skip to content
Inciteful Med

Symptoms & Warning Signs of Myotonic Dystrophy (DM1)

Last updated:

Myotonic Dystrophy Type 1 (DM1) causes delayed muscle relaxation, progressive weakness, and excessive daytime sleepiness. As a multisystem disorder, it also affects the heart, lungs, eyes, and digestive tract, making regular full-body medical monitoring essential.

Key Takeaways

  • • Grip myotonia, or the inability to quickly relax muscles after use, is a hallmark early sign of DM1.
  • • DM1 is a multisystemic disorder that can affect the heart, lungs, eyes, digestive tract, and hormone levels alongside the muscles.
  • • Regular cardiac monitoring is essential because heart conduction delays and arrhythmias are common but often silent.
  • • Excessive daytime sleepiness and fatigue are central nervous system symptoms that can severely impact daily life.
  • • Disease progression is typically slow, and symptom severity varies widely between individuals.

Because Myotonic Dystrophy Type 1 (DM1) is a multisystemic disorder, it affects much more than just the muscles [1]. Symptoms can appear in various parts of the body, often at different times, and their severity varies significantly from person to person [2]. Understanding these symptoms as part of a single condition can help you and your medical team provide more coordinated care.

Core Neuromuscular Symptoms

The most recognizable features of DM1 involve the skeletal muscles. These symptoms typically follow a predictable pattern:

  • Myotonia: This is the hallmark symptom of DM1, where muscles have difficulty relaxing after they are used [3]. The most common example is grip myotonia, where a person cannot quickly let go of a doorknob, a tool, or a hand after a handshake [4]. Tip: If you experience grip myotonia during a handshake or while holding something, you can simply explain to friends or coworkers, ‘I have a muscle condition that sometimes makes my hand muscles slow to let go—it just takes me a second!’
  • Progressive Muscle Weakness: Over time, muscles may become weaker. In DM1, this weakness usually starts in the distal muscles (those furthest from the center of the body, like the hands and ankles) and the facial muscles [5][6].
  • Muscle Wasting (Atrophy): As muscles weaken, they may also begin to thin or lose volume [3].

Systemic (Whole-Body) Symptoms

DM1 affects many organ systems. Because these issues can sometimes be “silent,” regular Long-Term Surveillance is vital [7].

  • Cardiac (Heart): Up to 80% of people with DM1 develop heart-related issues [8]. The most common are conduction delays (where electrical signals in the heart travel slowly) and arrhythmias (irregular heartbeats) [9][10]. These require annual monitoring via ECG or Holter monitor [11].
  • Respiratory (Breathing): Weakness in the diaphragm and other breathing muscles can lead to sleep-disordered breathing, such as sleep apnea [12]. This can cause low oxygen levels at night and is the leading cause of serious complications in DM1 [13][14].
  • Ocular (Eyes): Many patients develop early-onset cataracts, often before the age of 50 [15][16].
  • Gastrointestinal (GI): Issues like difficulty swallowing (dysphagia), bloating, constipation, or gallbladder stones are common because the “smooth muscles” in the digestive tract are also affected [17][18].
  • Endocrine (Hormones): DM1 can cause insulin resistance (similar to Type 2 diabetes), low testosterone in men (hypogonadism), and thyroid issues [19][16][20].

Central Nervous System (Brain) Symptoms

The condition also affects the brain, leading to “non-motor” symptoms that can significantly impact daily life [21]:

  • Excessive Daytime Sleepiness (EDS): Many people feel an overwhelming urge to sleep during the day, which is often caused by the brain’s regulation of sleep [22][23]. Because this sleepiness is a primary symptom originating in the central nervous system, it may persist even if breathing issues like sleep apnea are fully treated with a BiPAP machine at night [12].
  • Apathy and Fatigue: A lack of motivation or “get-up-and-go” (apathy) is a recognized symptom of the disease’s effect on the brain, as is profound physical and mental fatigue [24].
  • Cognitive Changes: Some patients may experience “brain fog” or difficulties with executive functions, such as planning, attention, or organizing tasks [24][21].

Variability and Progression

DM1 is known for its wide range of presentations. Some individuals may only have mild cataracts in their 60s, while others may experience significant muscle weakness in their 20s [25]. While the disease is progressive—meaning symptoms typically change over many years—the rate of change is generally slow [26]. Regular check-ups allow your specialists to manage these symptoms early and effectively [27].

Frequently Asked Questions

Why do I have trouble letting go of objects like doorknobs or handshakes?
This is a hallmark symptom of Myotonic Dystrophy Type 1 called grip myotonia. It happens because your muscles have difficulty relaxing immediately after they are used or flexed.
Why am I so sleepy during the day even if I sleep well at night?
Excessive daytime sleepiness in DM1 is often caused by the disease's effect on the central nervous system and brain, which regulate sleep. While it can also be linked to nighttime breathing issues like sleep apnea, the sleepiness may persist even if those breathing problems are treated.
What kind of heart problems can occur with myotonic dystrophy?
Up to 80% of people with DM1 develop heart issues, most commonly conduction delays where electrical signals travel slowly, and irregular heartbeats called arrhythmias. These issues are often silent at first, which is why annual heart monitoring is critical.
Can DM1 cause digestive issues like bloating or difficulty swallowing?
Yes, DM1 can affect the smooth muscles of the gastrointestinal tract. This can lead to various digestive symptoms including difficulty swallowing, bloating, constipation, and even gallbladder stones.
How quickly will my myotonic dystrophy symptoms progress?
Myotonic Dystrophy Type 1 is a progressive disease, meaning symptoms change and worsen over time, but the rate of progression is generally very slow. The severity and timeline of symptoms vary significantly from person to person.

Questions for Your Doctor

  • • Which specialists (cardiology, pulmonology, endocrinology) should be part of my core care team based on my current symptoms?
  • • Are the GI issues I’m experiencing, like bloating or constipation, related to DM1, and how should we manage them?
  • • Is my daytime sleepiness a sign of respiratory weakness at night, or is it a central nervous system symptom of the disease?
  • • What are the early signs of cardiac conduction issues I should look out for at home?
  • • Can you explain how myotonic dystrophy might affect my blood sugar and hormone levels?

Questions for You

  • • Have you noticed any difficulty relaxing your hand after gripping a doorknob, tool, or handshake?
  • • Do you find yourself feeling excessively sleepy during the day, even after a full night's rest?
  • • Have you experienced any 'fluttering' in your chest or felt faint or lightheaded recently?
  • • Have you noticed any changes in your vision, specifically cloudiness or blurring that could indicate cataracts?
  • • Have you had any trouble swallowing or felt like food gets stuck in your throat?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

    Meola G, Cardani R

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2017; (38(4)):535-546 doi:10.1007/s10072-016-2805-5.

    PMID: 28078562
  2. 2

    Factors Influencing the Severity and Progression of Respiratory Muscle Dysfunction in Myotonic Dystrophy Type 1.

    Hartog L, Zhao J, Reynolds J, et al.

    Frontiers in neurology 2021; (12()):658532 doi:10.3389/fneur.2021.658532.

    PMID: 33927684
  3. 3

    Cells of Matter-In Vitro Models for Myotonic Dystrophy.

    Matloka M, Klein AF, Rau F, Furling D

    Frontiers in neurology 2018; (9()):361 doi:10.3389/fneur.2018.00361.

    PMID: 29875732
  4. 4

    Mexiletine in Myotonic Dystrophy Type 1: A Randomized, Double-Blind, Placebo-Controlled Trial.

    Heatwole C, Luebbe E, Rosero S, et al.

    Neurology 2021; (96(2)):e228-e240 doi:10.1212/WNL.0000000000011002.

    PMID: 33046619
  5. 5

    External Ophthalmoplegia and Brainstem White Matter Lesions: Presentation of Myotonic Dystrophy Type 1.

    Igreja L, Ribeiro L, Cardoso M, et al.

    The neurologist 2023; (28(1)):54-56 doi:10.1097/NRL.0000000000000438.

    PMID: 35442941
  6. 6

    Overground exoskeletons may boost neuroplasticity in myotonic dystrophy type 1 rehabilitation: A case report.

    Portaro S, Naro A, Leo A, et al.

    Medicine 2019; (98(46)):e17582 doi:10.1097/MD.0000000000017582.

    PMID: 31725606
  7. 7

    Echocardiographic Features of Cardiac Involvement in Myotonic Dystrophy 1: Prevalence and Prognostic Value.

    Russo V, Capolongo A, Bottino R, et al.

    Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051947.

    PMID: 36902735
  8. 8

    Aberrant Expression of a Non-muscle RBFOX2 Isoform Triggers Cardiac Conduction Defects in Myotonic Dystrophy.

    Misra C, Bangru S, Lin F, et al.

    Developmental cell 2020; (52(6)):748-763.e6 doi:10.1016/j.devcel.2020.01.037.

    PMID: 32109384
  9. 9

    Idiopathic ventricular fibrillation and the V1764fsX1786 frameshift mutation of the SCN5A gene in a myotonic dystrophy type 1 patient.

    Shimoyama T, Hayashi H, Suzuki F, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020; (74()):242-244 doi:10.1016/j.jocn.2020.02.007.

    PMID: 32063450
  10. 10

    Heart transplantation in a patient with Myotonic Dystrophy type 1 and end-stage dilated cardiomyopathy: a short term follow-up.

    Papa AA, Verrillo F, Scutifero M, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(4)):267-271.

    PMID: 30944906
  11. 11

    [Myotonic dystrophy type 1 - a rare cause of bradycardia in the young].

    Kataja Knight A, Tidehag L, Mattsson G, Magnusson P

    Lakartidningen 2020; (117()).

    PMID: 31961442
  12. 12

    Respiratory function and sleep in children with myotonic dystrophy type 1.

    Cheminelle M, Nougues MC, Isapof A, et al.

    Neuromuscular disorders : NMD 2023; (33(3)):263-269 doi:10.1016/j.nmd.2023.01.008.

    PMID: 36780729
  13. 13

    Myotonic dystrophy type 1 and pulmonary embolism: successful thrombus resolution with dabigatran etexilate therapy.

    Gallinoro E, Papa AA, Rago A, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(3)):227-231.

    PMID: 30838353
  14. 14

    Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1.

    Wu S, Prahlow JA

    The American journal of forensic medicine and pathology 2025; (46(4)):330-336 doi:10.1097/PAF.0000000000001073.

    PMID: 40928346
  15. 15

    Myotonic Muscular Dystrophies.

    Johnson NE

    Continuum (Minneapolis, Minn.) 2019; (25(6)):1682-1695 doi:10.1212/CON.0000000000000793.

    PMID: 31794466
  16. 16

    Dissecting Pathogenetic Mechanisms and Therapeutic Strategies in Drosophila Models of Myotonic Dystrophy Type 1.

    Souidi A, Zmojdzian M, Jagla K

    International journal of molecular sciences 2018; (19(12)) doi:10.3390/ijms19124104.

    PMID: 30567354
  17. 17

    Clinical and genetic characteristics of childhood-onset myotonic dystrophy.

    Stokes M, Varughese N, Iannaccone S, Castro D

    Muscle & nerve 2019; (60(6)):732-738 doi:10.1002/mus.26716.

    PMID: 31520483
  18. 18

    Silent dysphagia in two patients with Steinert disease and recurrent respiratory exacerbations.

    Annunziata A, Valente T, Cauteruccio R, Fiorentino G

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(3)):141-143 doi:10.36185/2532-1900-019.

    PMID: 33305171
  19. 19

    Asymptomatic myocardial infarction in a patient with myotonic dystrophy type 1.

    Seki Y, Yamada T, Kiyosue A, et al.

    Journal of cardiology cases 2022; (26(4)):248-251 doi:10.1016/j.jccase.2022.05.004.

    PMID: 36187313
  20. 20

    Primary amenorrhea in myotonic dystrophy type 1: Initial presentation versus incidental finding on whole genome sequencing.

    Damon J, Chase C, Higashimoto T

    American journal of medical genetics. Part A 2024; (194(9)):e63650 doi:10.1002/ajmg.a.63650.

    PMID: 38709060
  21. 21

    Cognitive Deficits, Apathy, and Hypersomnolence Represent the Core Brain Symptoms of Adult-Onset Myotonic Dystrophy Type 1.

    Miller JN, Kruger A, Moser DJ, et al.

    Frontiers in neurology 2021; (12()):700796 doi:10.3389/fneur.2021.700796.

    PMID: 34276551
  22. 22

    Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1.

    Ho G, Widger J, Cardamone M, Farrar MA

    Sleep medicine 2017; (32()):92-96 doi:10.1016/j.sleep.2016.12.005.

    PMID: 28366348
  23. 23

    Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep staging.

    Bonanni E, Carnicelli L, Crapanzano D, et al.

    Neuromuscular disorders : NMD 2018; (28(5)):414-421 doi:10.1016/j.nmd.2018.02.004.

    PMID: 29631952
  24. 24

    Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.

    Fujino H, Shingaki H, Suwazono S, et al.

    Muscle & nerve 2018; (57(5)):742-748 doi:10.1002/mus.26022.

    PMID: 29193182
  25. 25

    [Medical emergency card for Steinert's disease: an unmet need].

    Rosado-Bartolomé A, Domínguez-González C

    Revista de neurologia 2023; (76(1)):15-19 doi:10.33588/rn.7601.2022380.

    PMID: 36544372
  26. 26

    Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.

    van der Plas E, Gutmann L, Thedens D, et al.

    Muscle & nerve 2021; (63(4)):553-562 doi:10.1002/mus.27174.

    PMID: 33462896
  27. 27

    Myotonic dystrophy type 2: the 2020 update.

    Meola G

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2020; (39(4)):222-234 doi:10.36185/2532-1900-026.

    PMID: 33458578

This page provides educational information about the symptoms of Myotonic Dystrophy Type 1 (DM1). It is not a substitute for professional medical evaluation or advice from your healthcare team.

Stay up to date

Get notified when new research about Steinert myotonic dystrophy is published.

No spam. Unsubscribe anytime.